News
PromarkerD is a potential diagnostic tool to demonstrate the benefits of canagliflozin in diabetic kidney disease
Recent Posts
January 2025
News Archive
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Subscribe
Subscripe to:
All Company news and updates
PromarkerD updates
PromarkerEso updates
PromakerEndo updates
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Name
This field is for validation purposes and should be left unchanged.
Company
About Us
Mission Statement
Senior Staff
Board of Directors
Clinical Advisory Board
Customer Testimonials
Quality Control
Careers
Glossary
Promarker™ Pipeline
PromarkerD
PromarkerEndo
PromarkerEso
OxiDx
Project Statuses
Biomarker Discovery
Analytical Services
Pharmacokinetics
Biomarker Services
Protein Analysis
Project Consultation
Pricing and Ordering – Commercial
Pricing and Ordering - Local WAP
Downloads
Terms and Conditions
FAQs
Newsroom
News & Media
Newsletters
Publications
Events and Presentations
Investors
ASX Announcements
Share Price and Analyst Coverage
Library
Reports
Corporate Governance
Shareholder Information
Annual General Meeting
Contact
Sample Delivery
Technical
Business Development
Provide your feedback
